In the EU/EEA, respiratory illness activity remains at baseline or low levels. SARS-CoV-2 is the main contributor, and its circulation continues to increase in several

In the EU/EEA, respiratory illness activity remains at baseline or low levels. SARS-CoV-2 circulation continues to increase in several countries. Influenza and RSV activities remain

In the EU/EEA, respiratory illness activity remains at baseline or low levels, although seasonal increases are being observed. While SARS-CoV-2 circulation remains low in most

As the colder months approach in Europe, respiratory infections including influenza, respiratory syncytial virus (RSV) infections, COVID-19, pneumococcal disease and others can lead to serious

As the colder months approach in Europe, respiratory infections including influenza, respiratory syncytial virus (RSV) infections, COVID-19, pneumococcal disease and others can lead to serious

In the EU/EEA, SARS-CoV-2 circulation remains low, although higher rates in two countries are affecting the overall picture. Respiratory syncytial virus and influenza circulation remain

This issue of the Communicable disease threats report (CDTR) covers the period 10 – 16 October 2026, and includes updates on respiratory virus epidemiology in

In the EU/EEA, increased circulation of SARS-CoV-2 is observed, with limited impact on hospitalisations. Respiratory syncytial virus and influenza circulation remain at low levels. 

This issue of the Communicable disease threats report (CDTR) covers the period 3 – 9October 2026, and includes updates on respiratory virus epidemiology in the

This issue of the Communicable disease threats report (CDTR) covers the period 26 September – 2 October 2026, and includes updates on Crimean Congo haemorrhagic

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 19-25 September, and includes updates on respiratory virus epidemiology in the EU/EEA

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 12-18 September, and includes updates on Ebola, malaria, botulism, avian influenza A(H9N2),